Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Èíôîðìàöèÿ è êîììåð÷åñêàÿ ðåêëàìà > Îçîíîòåðàïèÿ

Îçîíîòåðàïèÿ Ðàçäåë çàêðûò äëÿ ïóáëèêàöèè ñîîáùåíèé.

 
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 29.01.2005, 20:11
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íó ïðàâäà? ×åì øàìïàíèäû õóæå îçîíèäîâ?

Êîììåíòàðèè ê ñîîáùåíèþ:
SergeyPlyasunov îäîáðèë(à): Øàìïàíèäû - êðóòî!
  #17  
Ñòàðûé 29.01.2005, 20:18
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Öèòàòà:
Ñîîáùåíèå îò Dobro
ß íå çàíèìàþñü çëîñëîâèåì, ÿ âîçìóùàþñü äî ãëóáèíû äóøè íåäîáðîñîâåñòíîñòüþ è ïðîñòî ïðåñòóïíîé äåÿòåëüíîñòüþ íåêîòîðûõ îòå÷åñòâåííûõ âðà÷åé.
Òàê ìîæåò Âû âñå æå îòâåòüòå, Âàëåíòèí Àëåêñàíäðîâè÷,
íà âîïðîñû, êîòîðûå ÿ Âàì çäåñü çàäàë (ñîîáùåíèå ¹ 9)?
×åì, ê ïðèìåðó, Âàøå âîçìóùåíèå äî ãëóáèíû äóøè, î âåùàõ, êîòîðûå Âû íå çíàåòå, à Âàì òàê êàæåòñÿ, îòëè÷àåòñÿ îò ãëóáî÷àéøåãî âîçìóùåíèÿ ñîâåòñêèõ ãðàæäàí, ýêñïëóàòàöèåé ðàáî÷åãî êëàññà ïðè çàãíèâàþùåì êàïèòàëèçìå ?
  #18  
Ñòàðûé 29.01.2005, 20:31
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Öèòàòà:
Ñîîáùåíèå îò E.E. Studentsov
Íó ïðàâäà? ×åì øàìïàíèäû õóæå îçîíèäîâ?
Ðàçáåðåì äëÿ íà÷àëà, ÷åì øàìïàíèäû õóæå, ê ïðèìåðó, ôòîðõèíîëîíîâ.
Çàòåì ïåðåéäåì ê îçîíèäàì.
  #19  
Ñòàðûé 29.01.2005, 20:31
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
×åì, ê ïðèìåðó, Âàøå âîçìóùåíèå äî ãëóáèíû äóøè, î âåùàõ, êîòîðûå Âû íå çíàåòå...
Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷,

À ïî÷åìó Âû âîçìóòèëèñü ïî ïîâîäó ñðàâíåíèÿ âàøåãî äåòèùà ñ øàìïàíîòåðàïèåé? Âû ÷òî ñòàëêèâàëèëàñü ñ íåé? Âû èìååòå î íåé ïðåäñòàâëåíèå? Êàê Âû ìîæåòå ðàññóæäàòü äàæå íå ïîïðîáîâàâ? Èëè Âû çà? Èç-çà ïàòðèîòè÷åñêèõ ÷óâñòâ!!!!

Êîììåíòàðèè ê ñîîáùåíèþ:
Zhivov îäîáðèë(à): Super!!! Âëàäèìèð ßêîâëåâè÷, à ïðàâäà ÷åì íå êàéô øàìïàíñêîå â êëèçìå? Èëè òàì ïèâî Áàëòèêà ¹7?
  #20  
Ñòàðûé 29.01.2005, 20:37
Àâàòàð äëÿ Dobro
Dobro Dobro âíå ôîðóìà
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.09.2003
Ñîîáùåíèé: 466
Dobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
÷òî Âàì ëè÷íî èçâåñòíî ïðî îçîíîòåðàïèþ?
Òî ÷òî ýòî 1)ýêñïåðèìåíòàëüíàÿ ìåòîäèêà
2)íå ðåêîìåíäóåòñÿ ê èñïîëüçîâàíèþ â îôèöèàëüíîé ìåäèöèíå â ÑØÀ, Êàíàäå, ßïîíèè, Ôðàíöèè è ò.ä è ò.ï. Îá ýòîì ëåãêî óçíàòü ëþáîìó ÷åëîâåêó, ïîçâîíèâ èëè íàïèñàâ ïèñüìî â ÀÌÀ (American Medical Association) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
3)òåîðåòè÷åñêàÿ áàçà ñêóäíàÿ, èññëåäîâàíèé ïî áåçîïàñíîñòè è ýôôåêòèâíîñòè êðàéíå ìàëî. Îá ýòîì ìîæíî óçíàòü, ñäåëàâ çàïðîñ â ÌåäËàéí [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] èëè Ñochrane [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Ïî÷åìó íàäî âåðèòü èì, à íå âðà÷àì, ñïåöèàëèñòàì ðàçíûõ ñòðàí ìèðà, êîòîðûå íè îäèí ãîä ñ ýòîé òåðàïèåé ñâÿçàíû, èññëåäóþò?
Åñëè îçîíîòåðàïåâòû îïóáëèêóþò ñâîè äàííûå â ñîîòâåòñòâóþùèõ æóðíàëàõ ( ïî ëå÷åíèþ óðîëîãè÷åñêèõ ïðîáëåì â "Journal of Urology", ïî ëå÷åíèþ àñòìû â "Chest") òîãäà áóäåò âîçìîæíîñòü îöåíèòü èõ ðåçóëüòàòû.

Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Ïî÷åìó Âû ñïðàøèâàåòå, îòêóäà ïîÿâèëèñü «ýòè âñå ïîêàçàíèÿ äëÿ îçîíîòåðàïèè»? Âû ÷òî çíàêîìû ñ ïóáëèêàöèÿìè ñîòåí ýêñïåðèìåíòàëüíûõ è êëèíè÷åñêèõ ðàáîò ïî ýòîé òåðàïèè? ×òî äàåò Âàì ïðàâî äåëàòü óòâåðæäåíèÿ òèïà: «Ïîòðÿñàþùå áåççàñòåí÷èâîå âðàíü¸»? Âàì îòêóäà ýòî èçâåñòíî?
Ñì. âûøå

Êîììåíòàðèè ê ñîîáùåíèþ:
SergeyPlyasunov îäîáðèë(à): Âñ¸ àáñîëþòíî ÷¸òêî!
  #21  
Ñòàðûé 30.01.2005, 04:12
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé Åâãåíèé Åâãåíüåâè÷!
Ãäå ÿ âîçìóòèëñÿ? Çà÷åì Âû ïðèâåëè öèòàòó, êîòîðàÿ îòíîñèòñÿ ñîâñåì ê äðóãîìó òåêñòó. Òåì áîëåå ðå÷ü òàì èäåò íå î ìîåì âîçìóùåíèè äî ãëóáèíû äóøè, à Âàëåíòèí Àëåêñàíäðîâè÷à. Ïðîñòèòå, íî ó Âàñ óæå íå ïåðâûé ðàç ãàëëþöèíàöèè.
ß ëèøü ïîïðîñèë Âàñ, êàê ñïåöèàëèñòà ïî øàìïàíèäàì, ñðàâíèòü, âíà÷àëå, èõ ñ ôòîðõèíîëîíàìè.
  #22  
Ñòàðûé 30.01.2005, 05:04
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Tanya G
Îí [Zaitsev] , õîòü è íå âðà÷, íî î÷åíü ãðàìîòíûé áèîõèìèê
Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷,

Âû æå ó íàñ "íó î÷åíü ãðàìîòíûé áèîõèìèê" - âîò Âû è ñðàâíèâàéòå.
  #23  
Ñòàðûé 30.01.2005, 20:02
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Ìåíÿ, âìåñòå ñ îçîíîòåðàïèåé, íà ôîðóìå óæå íè ðàç ïðèãâîæäàëè ê ïîçîðíîìó ñòîëáó çà øèðîêèé ïåðå÷åíü ïàòîëîãèé, ïðè êîòîðûõ ÎÒ ïîêàçàíà. ß óæå íåñêîëüêî ðàç ïîÿñíÿë, ÷òî ëå÷èò íå îçîí, à îðãàíèçì. ×òî ñïåöèôè÷åñêèé èììóíèòåò îòäåëüíî äëÿ ãðèïïà, îòäåëüíî äëÿ ãåðïåñà - ëèøü ÷àñòü èììóíèòåòà, áîëüøèíñòâî ôàêòîðîâ èììóíèòåòà åäèíû äëÿ ðàçëè÷íûõ èíôåêöèé. ×òî óëó÷øåíèå êðîâîòîêà, óñèëåíèå ìåòàáîëèçìà êðàñíîé êðîâè õîðîøî äëÿ ëþáûõ ïàòîëîãèé, ñâÿçàííûõ ñ èøåìèåé è ò.ï.
Ïðåêðàñíî, Âëàäìèèð ßêîâëåâè÷! À â ÷åì ïî Âàøåìó çàêëþ÷àåòñÿ öåëåáíûé ýôôåêò õîðîøåé âåíòèëÿöèè ïàëàòû, ðàííåé àêòèâèçàöèè áîëüíîãî ïîñëå îïåðàöèè, ïðàâèëüíî ïîäîáðàííîé äèåòû, õîðîøåãî è ðåãóëÿðíîãî îïîðîæíåíèÿ êèøå÷íèêà, ïðîãóëîê íà ñâåæåì âîçäóõå, ëå÷åáíîé ôèçêóëüòóðû, êîìïðåññèîííûõ ÷óëîê íà ãîëåíÿõ áîëüíîãî è ìíîãîãî ïîäîáíîãî? Íàâåðíîå òî æå ïîä âîçäåéñòâèåì ýòèõ ìåðîïðèÿòèé âêëþ÷àåòñÿ "îðãàíèçüì" è ìîáèëèçóåòñÿ â áîðüáå ñ áîëåçíþ, óñèëèâàåòñÿ êðîâîòîê è ìåòàáîëèçüì, êà òî òàì ïëÿøóò âñÿ÷åñêèå ïîêàçàòåëè âñÿ÷åñêèõ àíàëèçîâ è ïð.? Òàê ÷åì òîãäà âñå âûøåïåðè÷èñëåííîå õóæå/ëó÷øå îçîíà? Çà÷åì íóæíû èìåííî âàùè ìàøèíêè è ÷åì îíè ëó÷øå äîáðîñîâåñòíîé óáîðùèöû è íîâîé øâàáðû? Òîëüêî òåì, ÷òî Âû èçâëåêàåòå ïðèáûëü èç èõ ïðîäàæè? Èç öèòèðîâàííûõ âàìè ðàáîò êàê ïðàâèëî íå ñëåäóåò, ÷òî âèíîâíèêîì òîðæåñòâà íàä âñåìè áîëåçíÿìè ÿâëÿåòñÿ èìåííî îçîí. È òîò ñàìûé èòàëüÿíåö, ëå÷èâøèé îçîíîì ñîñóäèñòûå ïîðàæåíèÿ íîã, ñêàçàë âñåãî ëèøü, ÷òî ìåòîä ïåðñïåêòèâåí è òðåáóåò äàëüíåéøåãî èçó÷åíèÿ. Ó íåãî óìà õâàòèëî íå ãîâîðèòü î òîì, ÷òî îçîí îäíîçíà÷íî õîðîø "îò âñåãî".

Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Ïðèâîäèë äîñòàòî÷íî áîëüøîå êîëè÷åñòâî ñîâåðøåííî íåçàâèñèìûå äðóã îò äðóãà èññëåäîâàíèÿ, ÷òî ñ ïîìîùüþ ÎÒ â êîìïëåêñíîé òåðàïèè óäàëîñü ñóùåñòâåííî ñíèçèòü ëåòàëüíîñòü ïðè ðàçëè÷íûõ ñåïòè÷åñêèõ ñîñòîÿíèÿõ. Ìíå â îòâåò: «íå äîêàçàíî», ìîæåò ïðîñòî â ïàëàòàõ ïîë ëó÷øå ïîìûëè èëè ìåäñåñòðà áîëåå âíèìàòåëüíàÿ. Îäíîçíà÷íîå óëó÷øåíèå öåëîãî ðÿäà ñóððîãàòíûõ ïîêàçàòåëåé òîæå íè÷åãî íå äîêàçûâàåò: â îðãàíèçìå íè÷åãî íåïîíÿòíî, êàêîé ïîêàçàòåëü çà ÷òî îòâå÷àåò. Ïîýòîìó ïîêà ÎÒ ïðè ïåðèòîíèòå íå èñïûòàþò â áîëüøèõ ÐÊÈ ñ ïëàöåáî, òî èñïîëüçîâàòü å¸ ïðåñòóïëåíèå. Íó, à åñëè ýòî íå òàê? Åñëè âñå æå âðà÷è, êîòîðûå íè îäèí ãîä ïðàêòèêóþò, ñðàâíèâàþò òåðàïèþ ïðàâû? ×òî ýòî èìåííî ÎÒ, à íå ïîìûòûé ïîë, ïîçâîëèëà ñïàñòè áîëüíûõ.
Âëàäèìèð ßêîâëåâè÷. Ñàìîå ïðîòèâíîå òî, ÷òî â íàøèõ áîëüíèöàõ ãîðàçäî ïðîùå ïîêóïàþòñÿ îçîíîâûå ìàøèíêè îò Çàéöåâà, ÷åì ðåêîíñòðóèðóþòñÿ ïîìåùåíèÿ, ìîþòñÿ ïîëû, óñòàíàâëèâàåòñÿ íîðìàëüíàÿ âåíòèëÿöèÿ, ïîâûøàåòñÿ ïðîôóðîâåíü âðà÷åé è âñåãî îñòàëüíîãî ìåäïåðñîíàëà (âìåñòå ñ çàðïëàòàìè), íàëàæèâàåòñÿ ñíàáæåíèå âñåì îäíîðàçîâûì (â íàøåì çäðàâîõðå èç îäíîðàçîâîãî òâåðäî â îáèõîä âîøëè òîëüêî øïðèöû, è òî õîðîøî). Êóïèòü ìàøèíêó âåäü ãîðàçäî ïðîùå ÷åì îñóùåñòâèòü âñå ýòè ñèñòåìíûå èçìíåíèÿ. Õîòÿ åñëè áû îíè ïðåòâîðèëèñü â æèçíü, âñå ýòè òîâàðèùè "äëèòåëüíî ïðàêòèêóþùèå ÎÒ" ñðàçó áû îöåíèëè èõ ýôôåêò.


Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Î÷åðåäíîé ðàç ñïðàøèâàþ, çà÷åì õèðóðãè, çíàêîìûå ñ ÎÒ ïî ìíîãîëåòíåé ïîâñåäíåâíîé ïðàêòèêå, ïðè ïåðåõîäå íà íîâîå ìåñòî ðàáîòû, àêòèâíî ñòðåìÿòñÿ ïîëó÷èòü ñîîòâåòñòâóþùåå îáîðóäîâàíèå? Èì ÷òî â íåîòëîæíîé õèðóðãèè çà îçîí ïðèïëà÷èâàþò?
Îòâåò î÷åâèäåí, Âëàäèìèð ßêîâëåâè÷. Îíè âèäèìî íåäîñòàòî÷íî óìåþò è çíàþò â ìåäèöèíå, ÷òî ïîçâîëÿëî áû èì òàê ëå÷èòü áîëüíûõ, ÷òîáû èì ðåàëüíî ïîìîãàòü, äà åùå è ïðèëè÷íî çàðàáàòûâàòü (çà õîðîøî ñäåëàííóþ ðàáîòó). Îäèí ìîé çíàêîìûé ä-ð, çà íåèìåíèåì ïàöèåíòîâ â åãî ÷àñòíîé îáùåâðà÷åáíîé ïðàêòèêå, ðåøèë ïîäçàíÿòüñÿ ìåòîäîì Ôîëëÿ. Íàäî ìíå áûëî åãî ñ Âàìè ïîçíàêîìèòü. Îçîíîå äåëî ïðèîáðåëî áû åùå îäíîãî ïî÷èòàòåëÿ.

Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Èëè, ê ïðèìåðó, èçðàèëüñêèå èëè èòàëüÿíñêèå áîëüíûå, êîòîðûì ñ ïîìîùüþ ÎÒ óäàëîñü ñîõðàíèòü íîãè îò àìïóòàöèè. Îïÿòü òóò ãîâîðÿò, ÷òî ïîëíîñòüþ íå äîêàçàíî, ÷òî ýòî îçîí. Ìîæåò ýòî ïðåäûäóùàÿ ìíîãîìåñÿ÷íàÿ òåðàïèÿ èìåííî â ýòîò ìîìåíò è ñðàçó ó âñåõ áîëüíûõ ñòàëà ðàáîòàòü. Íó, à åñëè âñå æå èçðàèëüñêèå è èòàëüÿíñêèå âðà÷è ïðàâû è ýòî èìåííî ÎÒ ñäâèíóëà ñ ìåðòâîé òî÷êè ëå÷åíèå? Íå áûëî áû ïðåñòóïëåíèåì åñëè áû îíè â ýòîì ñëó÷àå å¸ íå èñïîëüçîâàëè áû?
Âëàäèìèð ßêîâëåâè÷,
Îáî âñåõ "óñïåõàõ" ÎÒ, çàñëóæèâàþùèõ âíèìàíèÿ, èìåþòñÿ ëèøü åäèíè÷íûå ñîîáùåíèÿ î÷åíü óçêîé ãðóïïû àâòîðîâ èç îïðåäåëåííûõ ñòðàí. Ýòî âîâñå íå åñòü çàêîíîìåðíîñòü, êàê Âû ïîíèìàåòå.  ëó÷øåì ñëó÷àå íàõîäêè, òðåáóþùèå ïîäòâåðæäåíèé. Îá ýòîì, êñòàòè, ïðèëè÷íûå àâòîðû è ðåçþìèðóþò. Îíè, â îòëè÷èå îò Âàñ, íå ïîçèöèîíèðóþò ÎÒ êàê ïàíàöåþ. Îíè íå ïóáëèêóþò "ïîêàçàíèÿ" ê ÎÒ äëÿ ëå÷åíèÿ âñåõ áîëåçíåé. Èì õâàòàåò è óìà è ñîâåñòè íå íàçûâàòü â ëó÷øåì ñëó÷àå ýêñïåðèìåíòàëüíûé ìåòîä ðåàëüíî ñóùåñòâóþùèì. Âû êñòàòè ðàíüøå î÷åíü ÷àñòî ïðèâîäèëè Ãåðìàíèþ â êà÷åñòâå îàçèñà ÎÒ. Òåïåðü, êîãäà íåêîòîðûå ó÷àñòíèêè ôîðóìà, âêëþ÷àÿ óáåäèâøåãîñÿ â ýòîì ñàìîëè÷íî Âàøåãî ïîêîðíîãî ñëóãó, ñîîáùèëè, ÷òî îçîíîì â Ãåðìàíèè â ïðèëè÷íîì îáùåñòâå íå ïàõíåò, ÷åãî òî ïîóìîëêëè. Óâåðåí, ÷òî è â Èçðàèëå, è â Èòàëèè ýòîò ìåòîä íèêîãî âñðüåç íå èíòåðåñóåò. Äóìàþ, ÷òî ó÷àñòíèêè ôîðóìà èç Èçðàèëÿ ýòî ïîäòâåðäÿò.


Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Îïÿòü òàêè «Îçîíîòåðàïèÿ ó áåðåìåííûõ - ïðîñòî ïðåñòóïëåíèå!!!»
À æåíùèíû, êîòîðûì ãîäàìè áåçðåçóëüòàòíî ïîâòîðÿþò è ïîâòîðÿþò êóðñû ðàçëè÷íûõ àíòèáèîòèêîâ – íå ïðåñòóïëåíèå? Âåäü óæå ñîòíè, òûñÿ÷è æåíùèí, ïðîëå÷åííûõ ÎÒ â ðàçëè÷íûõ ËÓ áëàãîïîëó÷íî ðîäèëè çäîðîâûõ äåòåé Òàê ïî÷åìó æå ýòî ïðåñòóïëåíèå? Ïðè÷åì ìíå íåèçâåñòíî â Ðîññèè íè îäíîãî ñåðüåçíîãî ïîáî÷íîãî ýôôåêòà, ñâÿçàííîãî ñ îçîíîòåðàïèåé ó áåðåìåííûõ. Îçîíîòåðàïèè – ýòî áû íå ïðîñòèëè. Ñåðüåçíûå ïîáî÷íûå ýôôåêòû, âïëîòü äî ëåòàëüíûõ, ðàçðåøåíû òîëüêî äëÿ äîêàçàííûõ ëåêàðñòâ.
Ðàññóæäàòü íà ýòè òåìû ìîæíî òîëüêî ñ ôàêòàìè â ðóêàõ, êîòîðûõ Âû ïóáëèêå íå ïðåäëàãàåòå, Âëàäìèð ßêîâëåâè÷. Ïîáî÷íûå ýôôåêòû ëåêàðñòâ óñòàíàâëèâàþòñÿ ïðè òùàòåëüíîì ìîíèòîðèðîâàíèè èõ ïðèìåíåíèÿ

È ïîñëåäíåå, óâàæàåìûé Âëàäèìèð ßêîâëåâè÷. ß ïðåäëàãàë Âàì ñâîþ êàíäèäàòóðó â êà÷åñòâå îðãàíèçàòîðà è èñïîëíèòåëÿ êëèíèñïûòàíèé ìàñëà Îçîíèä íà áàçå êëèíèêè Àíäðîñ (åñëè ïîìíèòå ìû â ìåñÿö ïðèíèìàåì îêîëî 600 óðîëîãè÷åñêèõ è ãèíåêîëîãè÷åñêèõ áîëüíûõ). Òàê âîò, ÿ òàê è íå óñëûøàë íèêàêîãî âðàçóìèòåëüíîãî îòâåòà íà 2 ïðîñòûõ âîïðîñà:
1. Ïðåäïîëàãàåìàÿ íîçîëîãèÿ. ïðèêîòîðîé íàäî îöåíèòü ýôôåêòèâíîñòü îçîíèäà.
2. Êàêîâ áóäåò äèçàéí èññëåäîâàíèÿ.
ß ðèñêíó ñêàçàòü, ÷òî íàâåðíîå çíàþ äàæå ïî÷åìó ÿ íå óñëûøàë îòâåòîâ íà ýòè âîïðîñû. Âû ïðèâûêëè èñïûòûâàòü îçîí âî âñåõ èïîñòàñÿõ â "äèçàéíå" - "íà äîêòîð ïîïðîáóé è íàïèøè çàêëþ÷åíèå". Èíà÷å âàøå ïðåäëîæåíèå íîñèëî áû áîëåå îôîðìëåííûé õàðàêòåð. Òóò êàê òî ïðåäñòàâèòåëè ðîññéñêîé êîìïàíèè "Íèæôàðì" ïîñåòèëè îäíîãî ìîåãî êîëëåãó-ãèíåêîëîãà ñ ïðåäëîæåíèåì ïîïðîáîâàòü êàêèå òî òàì î÷åðåäíûå âëàãàëèùíûå ñâå÷êè. Íà âîïðîñ î äèçàéíå èññëåäîâàíèÿ ñíà÷àëà õîòåëè áûëî ñêàçàòü "íà äîêòîð ïîïðîáóé, ïîòîì íàïèøè çàêëþ÷åíèå". Íî äîêòîð îêàçàëñÿ ïîñëîæíåå ñðåäíåãî è ñïðîñèë ïðî äèçàéí èññëåäîâàíèÿ. Òå åìó ÷åðåç ïàðó äíåé ïðèïåðëè "äèçàéí" íå äàëåêî óøåäøèé îò èõ ïåðâîãî ïðåäëîæåíèÿ. Ïîòîì ñêàçàëè äîêòîðó - òû òèïà ñàì áû äèçàéí òî ïðèäóìàë äëÿ íàñ . à ïîòîì áû è ñàì èñïûòàë. È, ãëàâíîå, ýòî - çàêëþ÷åíèå òî íå çàáóäü, ÿñåí ïåíü êàêîå. Èç îáùåíèÿ ñ ýòîé ïóáëèêîé ñòàëî ïîíÿòíî, ÷òî âî âñåì "Íèæôàðìå" ëþäåé. êîòîðûå ïîíèìàþò ÷òî òàêîå êëèíè÷åñêèå èñïûòàíèÿ ïðîñòî íåòó! À çà÷åì îíè, åñëè Ìèíçäðàâ è òàê âñå ïîäðÿä è îò âñåãî ðåãèñòðèðóåò. Òàê âîò, Âëàäìèð ßêîâëåâè÷, ÿ ðèñêíó ïðåäïîëîæèòü, ÷òî ðàäóæíîñòü áóäóùåãî ÎÒ, êàê è ñâå÷åê îò "Íèæôàðìà" (âìåñòå ñ ñàìèìè íèæôàðàìàìè è ìåäîçîíàèì) ïðÿìî ïðîïîðöèîíàëüíî ñòåïåíè âõîæäåíèÿ íàøåé ñòðàíû â öèâèëèçàöèþ. ×åì áîëüøå ýòîé ñàìîé öèâèëèçàöèè ó íàñ áóäåò. òåì áóäåò è ìåíüøå âñÿêîãî ðîäà íåêà÷åñòâåííîãî è îòêðîâåííîãî øàðëàòàíñòâà. Ýòî ïîêàçàë è ïîêàçûâàåò îïûò âñåãî ìèðà, íå îáîéäåò îí ñ Áîæüåé ïîìîùüþ è Ðîññèþ.

Êîììåíòàðèè ê ñîîáùåíèþ:
doctor101 îäîáðèë(à): òîëêîâî, êîððåêòíî, ãðàìîòíî. Èçðàèëå ÎÒâ ñèñòåìå áîëüíè÷íûõ êàññ íå èñïîëüçóåòñÿ è íå îïëà÷èâàåòñÿ.
Melnichenko îäîáðèë(à):
Dobro îäîáðèë(à):
E.E. Studentsov îäîáðèë(à):
SergeyPlyasunov îäîáðèë(à):
  #24  
Ñòàðûé 30.01.2005, 22:02
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Öèòàòà:
Ñîîáùåíèå îò Zhivov
Çà÷åì íóæíû èìåííî âàùè ìàøèíêè è ÷åì îíè ëó÷øå äîáðîñîâåñòíîé óáîðùèöû è íîâîé øâàáðû? Òîëüêî òåì, ÷òî Âû èçâëåêàåòå ïðèáûëü èç èõ ïðîäàæè?
Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!
ß íåñêîëüêî ðàç ïðåäëàãàë Âàì îòîéòè îò îáùèõ äåìàãîãè÷åñêèõ ðàññóæäåíèé, îò ïàôîñà, ñ êîòîðûì îäèíàêîâî óñïåøíî ìîæíî âûñòóïàòü çà Ñîâåòñêóþ âëàñòü è ïðîòèâ íå¸, ê êîíêðåòíî ïîëó÷åííûì ðåçóëüòàòàì, ïîêàçàòåëÿì. Íàïðèìåð, ñîâñåì íåäàâíî ÿ äâàæäû ïîäðÿä ïðåäëàãàë Âàì
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
P.S. Åñëè åñòü âðåìÿ, ñðàâíèòå ïðîäîëæèòåëüíîñòü ýôôåêòà ïî óëó÷øåíèþ êðîâîòîêà ïðè èøåìèè ïîñëå ÎÒ, ê ïðèìåðó, ñ ãåïàðèíîì
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Àëåêñåé Âèêòîðîâè÷!
Âû çàãëÿíóëè â Èñïàíñêóþ ðàáîòó, êîòîðóþ ÿ ïðèâåë âûøå? À òî âåäü îïÿòü ñêàæèòå, ÷òî íå ïîìíèòå. Îáðàòèòå âíèìàíèå íà ôðàçó: Several studies that included control subjects have indicated that when ozone-free oxygen is used, the beneficial biochemical (7,10) and rheological (1) responses are not observed
Íî Âàì òàêèå îáñóæäåíèÿ íåñâîéñòâåííû. ß äàæå íå çíàþ, Âû õîòÿ áû ÷èòàåòå òî, ÷òî ÿ ïðèâîæó? Âàø ñòèëü ïîëåìèêè áîëüøå ñâîéñòâåíåí ïðîïîâåäíèêàì èëè ïîëèòðàáîòíèêàì. À òàê äèñêóòèðîâàòü óæå íå ïðèâûê ÿ.
Öèòàòà:
Ñîîáùåíèå îò Zhivov
Òàê âîò, ÿ òàê è íå óñëûøàë íèêàêîãî âðàçóìèòåëüíîãî îòâåòà íà 2 ïðîñòûõ âîïðîñà:
1. Ïðåäïîëàãàåìàÿ íîçîëîãèÿ. ïðèêîòîðîé íàäî îöåíèòü ýôôåêòèâíîñòü îçîíèäà.
2. Êàêîâ áóäåò äèçàéí èññëåäîâàíèÿ.
Èçâèíèòå, Àëåêñåé Âèêòîðîâè÷, íî îáíàðîäîâàíèå â òàêîì èñêàæåííîì ñâåòå íàøåé ïåðåïèñêè, íå äåëàåò Âàì ÷åñòè.

Êîììåíòàðèè ê ñîîáùåíèþ:
yananshs íå îäîáðèë(à):
  #25  
Ñòàðûé 30.01.2005, 22:24
Àâàòàð äëÿ Dobro
Dobro Dobro âíå ôîðóìà
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.09.2003
Ñîîáùåíèé: 466
Dobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDobro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷,
À äåéñòâèòåëüíî, êàêèì Bû ñåáå ïðåäñòàâëÿåòå äèçàéí èññëåäîâàíèÿ è ïðåäïîëàãàåìóþ íîçîëîãèþ äëÿ èññëåäîâàíèÿ ìàñëà "Îçîíèä" â óðîëîãè÷åñêîé êëèíèêå? Áîëüøîå ñïàñèáî çà îòâåò.
  #26  
Ñòàðûé 30.01.2005, 22:25
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!
Èçâèíèòå, Àëåêñåé Âèêòîðîâè÷, íî îáíàðîäîâàíèå â òàêîì èñêàæåííîì ñâåòå íàøåé ïåðåïèñêè, íå äåëàåò Âàì ÷åñòè.
Íàñêîëüêî ÿ ïîìíþ, óâàæàåìûé Âëàäèìèð ßêîâëåâè÷, ýòè âîïðîñû çàäàâàëèñü Âàì è âî âïîëíå îòêðûòîì ðåæèìå. ß äóìàë, ÷òî Âû èçíà÷àëüíî ïîñ÷èòàëè èõ ïðèâàòíûìè è íå îòâå÷àëè. Óæ êîëü ñêîðî ÿ íå ïîëó÷èë íà íèõ îòâåòà â îòêðûòóþ (ïðî ïåðåïèñêó Âû ïåðâûé íà÷àëè, ïðîñòèòå), ÿ çàäàë Âàì ýòè âîïðîñû è â ïèñüìå. Îòâåòà ÿ òàêæå íå ïîëó÷èë. Âìåñòî êîíêðåòèêè ðàçãîâîðû î òîì, ÷òî äå "ïðàâèëüíûå èññëåäîâàíèÿ" ñëèøêîì äîðîãè. Òàê âîò âìåñòî îáèä, ïîæàëóéñòà ëó÷øå ñôîðìóëèðóéòå ãäå â óðîëîãèè Âû áû ðåêîìåíäîâàëè èññëåäîâàòü ìàñëî Îçîíèä? Êàê èññëåäîâàòü? À ÷òî äî ïàôîñà, äà íåò ýòî ïðîñòî îáùèå çàêîíîìåðíîñòè, êîòîðûå ãåíåðèðóþòñÿ ïîä âëèÿíèåì îáùåíèÿ ñ Âàìè. Íå áîëåå òîãî. Ðàçãîâîð î ñðàâíåíèè ýôôåêòèâíîñòè ëå÷åíèÿ ñåïòè÷åñêèõ ñîñòîÿíèé: îçîí ïðîòèâ íàâåäåíèÿ ÷èñòîòû â ïàëàòàõ è óñòàíîâêè â íèõ íàäëåæàùèõ ñèñòåì î÷èñòêè âîçäóõà + âñå ÷òî êàñàåòñÿ áîëüíîãî - îäíîðàçîâîå + ãîñïèòàëüíûé àíòèáàêòåðèàëüíûé ïðîòîêîë, êóäà êàê àêòóàëåí è âïîëíå êîíêðåòåí.

Êîììåíòàðèè ê ñîîáùåíèþ:
E.E. Studentsov îäîáðèë(à):
  #27  
Ñòàðûé 31.01.2005, 00:36
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Àëåêñåé Âèêòîðîâè÷!
×òî êàñàåòñÿ ñåïñèñà è îçîíîòåðàïèè, ïîëàãàþ, äîñòàòî÷íî óáåäèòåëüíû ðåçóëüòàòû, íåìåöêèõ èññëåäîâàòåëåé íåñêîëüêèõ èí-òîâ óíèâåðñèòåòà Ìàðáóðãà, Ãåðìàíèÿ, êîòîðûå, ñ Âàøèõ ñëîâ, è ïðåñòàâëåíèÿ îá îçîíîòåðàïèè íå èìåþò.
Êðûñû ñàìöû ëèíèè Wistar ïðèìåðíî îäíîãî âåñà (180 - 200 ã), íàóãàä ðàñïðåäåëÿëèñü íà íåñêîëüêî ãðóïï. Âíóòðèáðþøèííîé èíúåêöèåé çàðàæåííîãî ôåêàëüíîãî ìàòåðèàëà ìîäåëèðîâàëñÿ ïåðèòîíèò.
Çàòåì íåêîòîðûå ãðóïïû îáðàáàòûâàëèñü ðàçëè÷íûìè àíòèáèîòèêàìè (öåôàëîñïîðèíàìè III–IV ïîêîëåíèÿ, ëåâîôëîêñàöèí, ïèïåðàöèëëèí + òàçîáàêòàì). Äðóãèå òåìå æå ñàìûìè àíòèáèîòèêàìè + ñèñòåìíàÿ îçîíîòåðàïèÿ (ïàðåíòåðàëüíûé îçîí â íèçêèõ äîçèðîâêàõ).
Ëåòàëüíîñòü êðûñ â ãðóïïàõ, ãäå èñïîëüçîâàëèñü ëèøü àíòèáèîòèêè, â çàâèñèìîñòè îò ÷óâñòâèòåëüíîñòè ê íèì èñïîëüçóåìîãî â ìîäåëè øòàììà è íà÷àëà ëå÷åíèÿ ïîñëå çàðàæåíèÿ, êîëåáàëàñü îò 80 äî 100 %.  òîæå âðåìÿ â ãðóïïàõ, ãäå âìåñòå ñ àíòèáèîòèêàìè èñïîëüçîâàëàñü îçîíîòåðàïèÿ óæå âûæèâàåìîñòü êðûñ êîëåáàëàñü îò 60 äî 100%.
Ê ïðèìåðó, ïðè èñïîëüçîâàíèè Piperacillin/Tazobactam âìåñòå ñ ÎÒ âûæèâàåìîñòü, â çàâèñèìîñòè îò íà÷àëà ëå÷åíèÿ ïîñëå çàðàæåíèÿ áûëà 100 è 78 %, à â ãðóïïàõ, ãäå ýòîò àíòèáèîòèê èñïîëüçîâàëñÿ áåç îçîíà – 0% !
Ýòè äàííûå ÿ ïðèâîäèë íà ôîðóìå íåñêîëüêî ðàç. È êàêàÿ áûëà ðåàêöèÿ?  ëó÷øåì ñëó÷àå: íó, è ëå÷èòå ñâîèì îçîíîì êðûñ.

P.S. Àëåêñåé Âèêòîðîâè÷. ß áû ìîã ñîäåéñòâîâàòü îáñóæäåíèþ òåðàïèè öåëûì ðÿäîì âðà÷åé, å¸ èñïîëüçóþùèõ, â òîì ÷èñëå, è çàðóáåæíûõ. Íî îáñòàíîâêà íåòåðïèìîñòè â äèñêóññèîííîì êëóáå, ê ëþáîìó ìíåíèþ, íåñîâïàäàþùåìó ñ ìíåíèåì ìåñòíûõ àâòîðèòåòîâ. Íàñàæäåíèå åäèíîìûñëèÿ ( êàê ó Êîçüìû Ïðóòêîâà "Ïðîåêò: î ââåäåíèÿ åäèíîìûñëèÿ â Ðîññèè") - ýòî îòâåðãàåò â êîðíå.
Äà è ó ìåíÿ óæå äàâíî íå âûçûâàåò áîëüøîãî óäîâîëüñòâèÿ ó÷àñòèå íà ýòîì ôîðóìå, áîëüøå ïî îáÿçàííîñòè.  ïåðâûå ãîäû, ÄÊ áûë çíà÷èòåëüíî áîëåå äåìîêðàòè÷íûé. Îäíî «ðàçâëå÷åíèå» íåêîòîðûõ ó÷àñòíèêîâ, êèäàòü ïðè ëþáîì óäîáíîì ñëó÷àå îïïîíåíòàì ÷åðíûå øàðû, ÷åãî ñòîèò!
Ê ïðèìåðó, îäíî èç ïîñëåäíèõ ã-íó Çàéöåâó â íàøåé ñ Âàìè äèñêóññèè
http://forums.rusmedserv.com/showpos...7&postcount=95
Âû ìîæåòå ïîÿñíèòü, ÷òî â íåì òàêîãî êðèìèíàëüíîãî?

Êîììåíòàðèè ê ñîîáùåíèþ:
E.E. Studentsov íå îäîáðèë(à):
  #28  
Ñòàðûé 31.01.2005, 01:09
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Àëåêñåé Âèêòîðîâè÷!
×òî êàñàåòñÿ ñåïñèñà è îçîíîòåðàïèè, ïîëàãàþ, äîñòàòî÷íî óáåäèòåëüíû ðåçóëüòàòû, íåìåöêèõ èññëåäîâàòåëåé íåñêîëüêèõ èí-òîâ óíèâåðñèòåòà Ìàðáóðãà, Ãåðìàíèÿ, êîòîðûå, ñ Âàøèõ ñëîâ, è ïðåñòàâëåíèÿ îá îçîíîòåðàïèè íå èìåþò.
Íàø îòâåò ïðî êðûñ îò 1/9/04:

Conclusion 1:Ozone pretreatment might prevent lethal peritonitis by controlling inflammatory process generated physiologically into the body against specific damage or specific organism.

Conclusions 2:Ozone pre-treatment was pro-inflammatory in sepsis with a trend to reduced survival. Therefore, its effects in sepsis should be further evaluated in animal trials.


Êàê áûòü îïïîíåíòàì? Êîìó âåðèòü? Ìîæåò ïðîâåðèì, íó õîòÿ áû åùå ðàçî÷åê, íó ïîæàëóéñòà, ïåðåä äåòñêèì òî îòäåëåíèåì...

Inflamm Res. 2004 Aug;53 Suppl 2:S122-5. Epub 2004 Aug 10. Related Articles, Links


Pre-treatment with ozonized oxygen (O(3)) aggravates inflammation in septic rats.

Torossian A, Ruehlmann S, Eberhart L, Middeke M, Wulf H, Bauhofer A.

Department of Anaesthesia and Critical Care, University of Marburg, Baldingerstrasse 1, 35033, Marburg, Germany, [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ].

Objective and design:Ozone is produced by neutrophils during bacterial killing. Its application was found to be beneficial in peritonitis patients. Therefore, we measured survival and cytokines after ozone pre-treatment in septic rats. Subjects and treatment:With approval, 40 male Wistar-rats were allocated to 1) ozone pre-treatment for five days before intra-abdominal sepsis, or 2) no pre-treatment. Methods:The primary endpoint was mortality at 120 h. Secondary endpoints were plasma cytokine levels. Results:In the control group mortality was 50% (10/20 rats). After ozone pre-treatment, survival was only 35% (7/20 rats, Log-Rank test: P = 0.10). Ozone increased TNF-alpha and MIP-2 after infection: 127+/-23 pg/ml and 94+/-19 pg/ml (control group: 398 pg/ml and 369 pg/ml; P < 0.002 and P < 0.01). IL-6 levels were similar in both groups. Conclusions:Ozone pre-treatment was pro-inflammatory in sepsis with a trend to reduced survival. Therefore, its effects in sepsis should be further evaluated in animal trials.

Âàø îòâåò: Ïîêà íå óâèæó ïîëíûé òåêñò ñòàòüè...

Âëàäèìèð ßêîâëåâè÷, óâèäåëè ïîëíûé òåêñò? Íåò. Ïîëó÷àéòå ÷åðíûé øàð. Çà íåæåëàíèå äàòü îòâåò ïî ñóùåñòâó, çà î÷åðåäíîé ïîâòîð, çà èñïîëüçîâàíèå íåäîêàçàííîé ìåòîäèêè íà áåðåìåííûõ è äåòÿõ è çà ïóñòóþ òðàòó íàøåãî âðåìåíè.

Êîììåíòàðèè ê ñîîáùåíèþ:
V. ZAITSEV íå îäîáðèë(à): Çà î÷åðåäíîå "ïåðåäåðãèâàíèå", ÷òî óæå âîøëî ó Âàñ â ïðèâû÷êó.
  #29  
Ñòàðûé 31.01.2005, 02:26
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Öèòàòà:
Ñîîáùåíèå îò E.E. Studentsov
Âàø îòâåò: Ïîêà íå óâèæó ïîëíûé òåêñò ñòàòüè... Âëàäèìèð ßêîâëåâè÷, óâèäåëè ïîëíûé òåêñò? Íåò. Ïîëó÷àéòå ÷åðíûé øàð. Çà íåæåëàíèå äàòü îòâåò ïî ñóùåñòâó, çà î÷åðåäíîé ïîâòîð, çà èñïîëüçîâàíèå íåäîêàçàííîé ìåòîäèêè íà áåðåìåííûõ è äåòÿõ è çà ïóñòóþ òðàòó íàøåãî âðåìåíè.
Ïîëíîñòüþ ìîé îòâåò áûë òàêîé.

Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
Óâàæàåìûé Åâãåíèé Åâãåíüåâè÷!
Ïîêà íå óâèæó ïîëíûé òåêñò ñòàòüè, è ãëàâíîå: èñïîëüçóåìûå â ýêñïåðèìåíòå äîçèðîâêè, êîììåíòèðîâàòü ïîëó÷åííûå ðåçóëüòàòû íåò íèêàêîé âîçìîæíîñòè. Êàê óæå íåñêîëüêî ðàç îòìå÷àë, ïðè îïðåäåëåííûõ (âûñîêèõ) äîçàõ ïàðàíòåðàëüíî ââåäåííûé îçîí îáëàäàåò óæå èììóííîñóïðåññèâíûì ýôôåêòîì.
Ñóäÿ ïî ïîâûøåíèþ óðîâíÿ ôàêòîðà íåêðîçà îïóõîëè â äàííîì ýêñïåðèìåíòå èñïîëüçîâàëèñü èìåííî òàêèå äîçèðîâêè. Ïî÷åìó? Íåïîíÿòíî. Âîçìîæíî îòâåò èìååòñÿ â òåêñòå ñòàòüè. Èëè ýêñïåðèìåíòàòîðû áûëè íåñâåäóùè.
Åù¸ ðàç õî÷ó îòìåòèòü: èç ôàêòà, ÷òî ïåðåäîçèðîâêà áàíàëüíûì ïàðàöåòàìîëîì ÷ðåâàòà ëåòàëüíûì èñõîäîì íå ñëåäóåò, ÷òî åãî íåîáõîäèìî ñðî÷íî èçûìàòü èç àïòåê.
Äà, Åâãåíèé Åâãåíüåâè÷.
ß óòî÷íèë êàêèå äîçèðîâêè ïðèìåíÿëèñü â öèòèðóåìîé Âàìè ñòàòüå: êàê è îæèäàëîñü, â íåñêîëüêî ðàç ïðåâûøàþùèå òåðàïåâòè÷åñêèå.
À íà Âàøå âðåìÿ ÿ íèêîãäà íå ïðåòåíäîâàë. Âû ïî ñîáñòâåííîé èíèöèàòèâå óæå äëèòåëüíîå âðåìÿ, ïîñòîÿííî çàíèìàåòåñü ïîèñêàì êîìïðîìàòà íà îçîíîòåðàïèþ. Êðîìå òîãî, íà ýòîò ðàç, î÷åðåäíóþ äèñêóññèþ íà ýòîì ôîðóìå èíèöèèðîâàë íå ÿ.

Êîììåíòàðèè ê ñîîáùåíèþ:
E.E. Studentsov íå îäîáðèë(à): Ñ äîêòîðîì Ãàçèíûì ÿ òîæå ïåðåäåðãèâàë?
  #30  
Ñòàðûé 31.01.2005, 07:32
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò V. ZAITSEV
ß óòî÷íèë êàêèå äîçèðîâêè ïðèìåíÿëèñü â öèòèðóåìîé Âàìè ñòàòüå: êàê è îæèäàëîñü, â íåñêîëüêî ðàç ïðåâûøàþùèå òåðàïåâòè÷åñêèå.
Êàê Âàì óäàëîñü ñäåëàòü ïîäîáíîå çàêëþ÷åíèå íå îçíàêîìèâøèñü ñ ðàáîòîé?

Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷,


Äâå ðàáîòû ïðîâîäèëèñü â îäíîì è òîì æå ãîðîäå - Ìàðáóðãå: îäíà â Phillips-University, a äðóãàÿ â University of Marburg. Ìîãó ïðåäïîëîæèòü, ÷òî âòîðàÿ ãðóïïà ïîîáùàëàñü ñ ïåðâîé, ò.å. äîêòîð À. Bauhofer ñêîðåå âñåãî ïîçâîíèë äîêòîðó M. Bette è ïåðåãîâîðèë î äèçàéíå è àïïàðàòóðå äëÿ áóäóùåãî èññëåäîâàíèÿ.
Ìû, êðîìå òîãî, èìååì âîçìîæíîñòü ñðàâíèòü äâå ðàáîòû, ò.ê. â íàó÷íûõ ñòàòüÿõ, â îòëè÷èå îò îçîíîòåðàïåâòè÷åñêèõ îïóñîâ, åñòü ñïåöèàëüíûé ðàçäåë ïîä íàçâàíèåì: "Ìàòåðèàëû è ìåòîäû".

Ðàáîòà äð. Áåòòå:

1. Healthy male Wistar ràts (210-215 g) they were kept in rooms with a standardized air conditioning 20-22 C, 50-57% relative humidity, and 12-hour artificial day/night rhythm.
2. "Ozonized oxygen was generated from medical by an ozone processor (Ozonosan, PTN 60 Dr. Hansler GmbH, Iffezheim, Germany) or from an Ozomed machine, manufactured at the Ozone Research Center in Havana, Cuba. Ozone concentrations were monitoried by using an Ozonosan photometer (Dr. Hansler GmbH). The gas mixture (5% volume ozone and 95% medical oxygen) was insufflated with a standardized volume of 80 ml/kg rat by injection (needle size: 21G) into the right abdominal of the rats by daily injection for 5 days.

A òåïåðü ðàáîòà äîêòîðà Áàóõîôåðà:
1. We used 40 male Wistar rats, 220-280 g. They were given a standard diet and water ad libitum.
2. "In the Group 1, 80 ml/kg of an ozone/oxygen gas mixture was given as an intraperitoneal injection on 5 consecutive days before surgery. An ozone generator, Ozonosan PNT 60 (Dr. J. Hansler GmbH, Iffezheim, Germany) was used for preparation of the gas mixture.

Ïîêà ïðîòîêîëû ïîõîæè, êàê äâå êàïëè âîäû, ò.å. åñëè äîêòîð Áàóõîôåð è íå ïåðåãîâîðèë ñ äîêòîðîì Áåòòå, òî îí ïðî÷èòàë åãî ðàáîòó, ò.ê. öåëüþ ðàáîòû äîêòîðà Áàóõîôåðà áûëî ïîäòâåðæäåíèå ðåçóëüòàòîâ äîêòîðà Áåòòå, î ÷åì îí è ãîâîðèò â ïðåäèñëîâèè ê ñâîåé ñòàòüå.

Òåïåðü î äîçàõ:

Äîêòîð Áåòòå: " In the surgical model different ozone concentrations (10 ug/ml, Xmean = 0.93 mg ozone /rat; 50 ug/ml, Xmean = 4.2 mg ozone /rat; 100 ug/ml, Xmean = 7.97 mg ozone/rat)". Äîêòîð Áåòòå äàåò ïîëíûå äîçû îçîíà, ïîëó÷åííûå çà 5 ñåàíñîâ.

A òåïåðü äîêòîð Áàóõîâåð, êîòîðûé ïîâòîðÿåò ïðîòîêîë Áåòòå (ñ ìèíèìàëüíîé èç òðåõ êîíöåíòðàöèé, òàê êàê îíà ïîêàçàëà ëó÷øèå ðåçóëüòàòû), äàâàÿ 80 ìë ñìåñè (ñîäåðæàùåé îçîíà 10 ug/ml) íà êã âåñà, ïîëó÷àÿ "An ozone/oxygen gas mixture (800 ug/kg)" è äàåò ýòî "on five consecutive days". Òî åñòü òî æå ñàìîå êîëè÷åñòâî îçîíà.


Ïîñëå íåóäà÷è ýêñïåðèìåíòà, äîêòîð Áàóõîâåð äåëàåò ïðåäïîëîæåíèå, ÷òî "the chosen dose of ozone, which was recommended by another group (ññûëêà íà ðàáîòó äîêòîðà Áåòòå), "was still too high to exclude negative immunological effects".

Òàê ÷òî ÿ íå ìîãó ñ âàìè ñîãëàñèòüñÿ, ÷òî äîêòîð Áàóõîôåð ïðèìåíèë íåâìåíÿåìî áÎëüøóþ êîíöåíòðàöèþ îçîíà è òåì ñàìûì ïîãóáèë êðûñ.
Îáà ó÷åíûõ ñîëèäàðíû â îäíîì: òðåáóþòñÿ äàëüíåéøèå ýêñïåðèìåíòû íà æèâîòíûõ.
Äîêòîð Áåòòå: "Therefore, more investigationwith this gas mixture are necessary, especially in combination with antibiotics which will lead to a promising new approach in prevention and /or therapy to overcome severe infectious diseases"
Äîêòîð Áàóõîâåð: "Although we cannot recommend pre-treatment with ozonized oxigen for patients at risk for peritonitis based on the result of our study, we conclude that further evaluation of ozone as a therapeutic or prophylactic measure including its mode of action is necessary in ANIMAL models, probably with reduced doses."


P.S. Èç ðàáîòû äîêòîðà Áàóõîôåðà: "We thanks Dr. S. Schults [laboratory of d-r M. Bette], Institute of Veterenary Medicine for supporting us with the ozone generator"


P.S. Èç ðàáîòû äîêòîðà Áåòòå: "Òhis study was supported by Dr. Viebahn-Hansler (Dr. Hansler GmbH, Germany) [ïðîèçâîäèòåëü îçîíîâûõ àïïàðàòîâ è "ãëàâíûé" íåìåöêèé îçîíîòåðàïåâò] + The work was partly performed in the National Scientific Research Center, Havana, the Ozone Research Center (Dr. Hernandez and Dr. Rosales, Cuba) [ îðãàíèçàöèÿ, èìåþùàÿ ïðÿìóþ ìàòåðèàëüíóþ çàèíòåðåñîâàííîñòü â ïðîäàæå îçîíîâûõ àïïàðàòîâ è ìåòîäèêè]

Êîììåíòàðèè ê ñîîáùåíèþ:
Íàòàëüÿ Ï. îäîáðèë(à):
 



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 02:36.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.